Morgan Stanley’s Molecular Partners MOLN Stock Holding History

Morgan Stanley’s Portfolio MOLN Stock Details MOLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.42K	Hold	367	–	–	﹤0.01%	7465
2026 Q1	$1.46K	Hold	367	–	–	﹤0.01%	7379
2025 Q4	$1.6K	Hold	367	–	–	﹤0.01%	7287
2025 Q3	$1.36K	Hold	367	–	–	﹤0.01%	7363
2025 Q2	$1.4K	Hold	367	–	–	﹤0.01%	7293
2025 Q1	$1.42K	Hold	367	–	–	﹤0.01%	7235
2024 Q4	$1.74K	Sell	367 -133	-27%	-$732	﹤0.01%	7222
2024 Q3	$2.54K	Buy	500 +133	+36%	+$813	﹤0.01%	7082
2024 Q2	$2.65K	Hold	367	–	–	﹤0.01%	7014
2024 Q1	$1.42K	Hold	367	–	–	﹤0.01%	7129
2023 Q4	$1.53K	Hold	367	–	–	﹤0.01%	7081
2023 Q3	$1.52K	Hold	367	–	–	﹤0.01%	7170
2023 Q2	$2.21K	Hold	367	–	–	﹤0.01%	7178
2023 Q1	$2.22K	Hold	367	–	–	﹤0.01%	7222
2022 Q4	$2.4K	Hold	367	–	–	﹤0.01%	7320
2022 Q3	$2K	Hold	367	–	–	﹤0.01%	7477
2022 Q2	$2K	Hold	367	–	–	﹤0.01%	7599
2022 Q1	$7K	Buy	+367	New	+$8.91K	﹤0.01%	7506
2021 Q3	–	Sell	-1,201	Closed	-$25K	–	7984
2021 Q2	$25K	Buy	+1,201	New	+$23.8K	﹤0.01%	6927

Other funds holding MOLN

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley's MOLN Position: Q2 2026 in Review

Morgan Stanley held its Molecular Partners (MOLN) position steady in Q2 2026 at 367 shares worth $1.42K. The position accounts for ﹤0.01% of the portfolio, ranked #7465.

Morgan Stanley first reported a position in MOLN in Q2 2021 and has held it in 19 quarters since. The position peaked at $25K in Q2 2021. 5 funds tracked by Wall St. Rank hold MOLN as of Q2 2026.

Morgan Stanley held 367 shares of Molecular Partners worth $1.42K as of Q2 2026.
Morgan Stanley left its Molecular Partners share count unchanged in Q2 2026.
Molecular Partners made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7465 holding.
Morgan Stanley first reported a position in Molecular Partners in Q2 2021 and has held it in 19 quarters since.
Morgan Stanley's Molecular Partners position peaked at $25K in Q2 2021.
5 funds tracked by Wall St. Rank held Molecular Partners as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.